Skip to main content
Livermore
Livermore
ZHEN

Bokf, NA

SEC CIK
0000009634
Latest filing
Aug 10, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Bokf, NA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
1,346
Value
$839.3K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of REGN by Bokf, NA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,346$839.3K<0.1%−5−0.4%ReducedHolders
Q1 20261,351$1.04M<0.1%−25−1.8%ReducedHolders
Q4 20251,376$1.06M<0.1%−172−11.1%ReducedHolders
Q3 20251,548$870.4K<0.1%−637−29.2%ReducedHolders
Q2 20252,185$1.15M<0.1%+14+0.6%AddedHolders
Q1 20252,171$1.38M<0.1%−1,032−32.2%ReducedHolders
Q4 20243,203$2.23M<0.1%+1,458+83.6%AddedHolders
Q3 20241,745$1.77M<0.1%−220−11.2%ReducedHolders
Q2 20241,965$2.07M<0.1%+120+6.5%AddedHolders
Q1 20241,845$1.79M<0.1%−30−1.6%ReducedHolders
Q4 20231,875$1.65M<0.1%+13+0.7%AddedHolders
Q3 20231,862$1.45M<0.1%−2,015−52.0%ReducedHolders
Q2 20233,877$2.79M0.1%+172+4.6%AddedHolders
Q1 20233,705$3.04M0.1%−834−18.4%ReducedHolders
Q4 20224,539$3.27M0.1%+495+12.2%AddedHolders
Q3 20224,044$2.79M0.1%+182+4.7%AddedHolders
Q2 20223,862$2.28M<0.1%−4−0.1%ReducedHolders
Q1 20223,866$2.70M<0.1%+143+3.8%AddedHolders
Q4 20213,723$2.35M<0.1%−38−1.0%ReducedHolders
Q3 20213,761$2.28M<0.1%–No prior filingHolders
Q2 2021––––Not filedHolders
Q1 20215,483$2.59M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.